Literature DB >> 30137575

Revival of the VEGF ligand family?

Simone P Niclou1,2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30137575      PMCID： PMC6178279          DOI： 10.1093/neuonc/noy127

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  12 in total

1.  Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

Authors:  S J Grau; F Trillsch; J Herms; N Thon; P J Nelson; J-C Tonn; R Goldbrunner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

Review 2.  Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials.

Authors:  Giuseppe Lombardi; Ardi Pambuku; Luisa Bellu; Miriam Farina; Alessandro Della Puppa; Luca Denaro; Vittorina Zagonel
Journal:  Crit Rev Oncol Hematol       Date:  2017-01-30       Impact factor: 6.312

3.  Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.

Authors:  Tracy T Batchelor; Elizabeth R Gerstner; Kyrre E Emblem; Dan G Duda; Jayashree Kalpathy-Cramer; Matija Snuderl; Marek Ancukiewicz; Pavlina Polaskova; Marco C Pinho; Dominique Jennings; Scott R Plotkin; Andrew S Chi; April F Eichler; Jorg Dietrich; Fred H Hochberg; Christine Lu-Emerson; A John Iafrate; S Percy Ivy; Bruce R Rosen; Jay S Loeffler; Patrick Y Wen; A Greg Sorensen; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

4.  Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.

Authors:  Sophie de Boüard; Paulette Herlin; James G Christensen; Edwige Lemoisson; Pascal Gauduchon; Eric Raymond; Jean-Sébastien Guillamo
Journal:  Neuro Oncol       Date:  2007-07-10       Impact factor: 12.300

Review 5.  Current status and future directions of anti-angiogenic therapy for gliomas.

Authors:  Wolfgang Wick; Michael Platten; Antje Wick; Anne Hertenstein; Alexander Radbruch; Martin Bendszus; Frank Winkler
Journal:  Neuro Oncol       Date:  2015-10-12       Impact factor: 12.300

6.  Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.

Authors:  Petra Hamerlik; Justin D Lathia; Rikke Rasmussen; Qiulian Wu; Jirina Bartkova; MyungHee Lee; Pavel Moudry; Jiri Bartek; Walter Fischer; Jiri Lukas; Jeremy N Rich; Jiri Bartek
Journal:  J Exp Med       Date:  2012-03-05       Impact factor: 14.307

7.  Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma.

Authors:  Nina Obad; Heidi Espedal; Radovan Jirik; Per Oystein Sakariassen; Cecilie Brekke Rygh; Morten Lund-Johansen; Torfinn Taxt; Simone P Niclou; Rolf Bjerkvig; Olivier Keunen
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-19       Impact factor: 6.200

Review 8.  Mechanisms and regulation of endothelial VEGF receptor signalling.

Authors:  Michael Simons; Emma Gordon; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-27       Impact factor: 94.444

Review 9.  The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis.

Authors:  Gina A Smith; Gareth W Fearnley; Darren C Tomlinson; Michael A Harrison; Sreenivasan Ponnambalam
Journal:  Biosci Rep       Date:  2015-08-18       Impact factor: 3.840

10.  VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.

Authors:  Signe R Michaelsen; Mikkel Staberg; Henriette Pedersen; Kamilla E Jensen; Wiktor Majewski; Helle Broholm; Mette K Nedergaard; Christopher Meulengracht; Thomas Urup; Mette Villingshøj; Slávka Lukacova; Jane Skjøth-Rasmussen; Jannick Brennum; Andreas Kjær; Ulrik Lassen; Marie-Thérése Stockhausen; Hans S Poulsen; Petra Hamerlik
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.